MedTrace Logo

Family Foundations for Special Education Trial

NCT07400497 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-02-10

No results posted yet for this study

Summary

The goal of this clinical trial is to assess the program's impact on parent self-efficacy and co-parental support around (a) accessing health and educational services and (b) parenting for co-parents of children with disabilities entering the Special Education system before their first Individualized Education Program (IEP) meeting. The main questions it aims to answer are: Does the program improve co-parenting support and coordination and parent efficacy in accessing services for and parenting their child? Does the program improve parent mental health, service access, engagement, and adherence? Does the program improve parenting quality? Does the program improve child adjustment (mental and behavioral health, academic engagement)? Researchers will compare pretest and posttest questionnaires from Treatment Group A with Control Group B to see if the program improves parent and child well-being, co-parenting relations, relations with service providers, ability to access services and meaningfully participate in IEP and other meetings.

Participants will:

* Complete pre- and post-test questionnaires
* Treatment Group A will participate in 6 learning sessions, each 1 hour to 1½ hour long, over a 6-8 week period

Conditions

Interventions

BEHAVIORAL

Family Foundations for Special Education

Families in the intervention group receive the new enhanced supports and participate in six private virtual learning sessions focused on understanding the special education system, improving communication, and enhancing collaboration as co-parents in the IEP process. Each session lasts 60-90 minutes and will be scheduled weekly according to the participants preferred schedule, including evenings and weekends. A workbook with supporting documents for each session will be sent to each participant prior to the start of the sessions.

Sponsors & Collaborators

  • Public Health Management Corporation

    collaborator OTHER

  • William Penn Foundation

    collaborator OTHER

  • Penn State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-12
Primary Completion
2026-03-31
Completion
2026-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07400497 on ClinicalTrials.gov